#12 SGLT2i / MRAs / GLP1s, with Katherine Tuttle
Listen now
Description
A Pinch of Salt today set sail very far away! We went to the other side of the Atlantic ocean, transversed a few thousand km or miles of land and finally got to Katherine Tuttle, from Washington USA, an eminent specialist on translational medicine who will « unconfuse » us on the « new drugs in nephrology » a series of innovative treatments or indications for currently existing ones. We‘ll talk about SGLT2 inhibitors, Mineralocorticoid receptor antagonists and many more! Because that's the objective of A Pinch of Salt! We are looking for common-sense answers to difficult clinically relevant questions. Our basic mission is to ask the questions a young nephrologist would want to ask at the ERA Congress but doesn’t have the guts to do so out of fear of appearing a simpleton. We firmly believe that the so-called “simple questions” may be the most important ones and are too rarely asked and answered. So join us for this most exciting exchange with an eminent specialist in the field.
More Episodes
In the latest episode of A Pinch of Salt check out 'Proteinuria - the common suspect', the most obvious whodunit in the pathophysiological process of kidney disease. Things are changing and I start being confused with the labile landscape of proteinuria. A huge number of mechanisms are presented...
Published 05/09/24
Is it itching you to know more about CKD-associated pruritus? Do not worry! ERA is there for you!Can you imagine that the number of patients with CKD-associated pruritus in your Unit is more important than your estimations?Do you also have a bunch of patients that you do not know what to do with...
Published 05/09/24
I don’t know how it is with you, but lupus has always been the disease that I hated the most. However, IgA nephropathy must be the one that I’m most frustrated about. Primarily, because I feel like there’s nothing I can do about it like I’m some kind of fraud just waiting for the patient to...
Published 05/09/24